Novartis AG annual revenue for fiscal 2025 was $56.7 billion, an increase of 9.6% from $51.7 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $56.7B | $51.7B | $46.7B | $43.5B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $15.0B | $13.5B | $13.9B | $14.4B | $14.8B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More NOVN metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow
All NOVN financial statements → Interactive NOVN charts →
About TickerBase · Data methodology & sources · Privacy · Terms